Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid
US8318856B2 · kind B2 · utility
12Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 4, 2008 |
| Grant date | Nov 27, 2012 |
| Priority date | — |
| Expiry date | Feb 11, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a delivery system for nucleic acid using a cationic polymer conjugate, and more specifically relates to a delivery system for nucleic acid comprising a cationic polymer conjugate prepared by conjugating hyaluronic acid or its derivative and polyethyleneimine, and a composition of delivering a nucleic acid into mammalian cell comprising a complex of the nucleic acid and a cationic polymer conjugate with electrostatic binding.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.